Skip to main content

Posts

Showing posts with the label Treatment of ADD and ADHD

Treatment of ADD/ADHD

By John Chen, PhD, PharmD, OMD, LAc Attention-deficit disorder and attention-deficit  hyperactivity disorder  (ADD/ADHD) are developmental conditions in which the affected person is unable to concentrate and is easily distracted, with or without accompanying hyperactivity. There must be an onset of symptoms before age 7 that causes significant social or academic impairment. The incidence of ADD/ADHD is 3 percent to 7 percent in school-age children, and 2 percent to 7 percent in adults. The pathology of ADHD is not clear. There is speculation that certain areas of the brain related to attention are deficient in neural transmission. The neurotransmitters dopamine and norepinephrine have been associated with ADD/ADHD. Stimulants such as Ritalin (methylphenidate) and Dexedrin (dextroamphetamine), are generally prescribed for treatment of ADD/ADHD. Common short-term side effects include significant insomnia, appetite suppression and  weight loss , headaches, mood fluct...